CCPG1

Across TCGA pan-cancer cohorts, CCPG1 mass-spec protein is linked to patient survival in 4 of 34 cancer types, making it a survival-associated CCPG1 data layer compared with 25 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher CCPG1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCPG1 expression acts as an unfavorable survival marker.

CCRCC, PDAC, and LSCC are the cancer types where CCPG1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	DFS	Median	III,IV	0.322	0.785	<.001	30	view →
PDAC	DFS	Tertile	All	0.298	0.499	.001	29	view →
LSCC	OS	Quartile	II,III,IV	0.448	1.000	<.001	15	view →
LUAD	DFS	Median	II,III,IV	0.773	1.000	.005	14	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

CCPG1–CCRCC (DFS)

Open the CCRCC breakdown →